“One area of criminal enforcement that will be a focus for the Criminal Division in the months and years ahead [is the] application of the Foreign Corrupt Practices Act (FCPA) to the pharmaceutical industry. We will be vigilant in holding companies and individuals who break the law accountable, not only through civil actions … but also by bringing criminal indictments if the facts and the laws warrant.” — Lanny A. Breuer, DoJ Assistant Attorney General, Criminal Division, November 12, 2009.
“Pharma and Device Companies are the Next Target for FCPA Investigations” “One area of criminal enforcement that will be a focus for the Criminal Division in the months and years ahead [is the] application of the Foreign Corrupt Practices Act (FCPA) to the pharmaceutical industry. We will be vigilant in holding companies and individuals who break the law accountable, not only through civil actions … but also by bringing criminal indictments if the facts and the laws warrant.” — Lanny A. Breuer, DoJ Assistant Attorney General, Criminal Division, November 12, 2009.
Register Now
In 90 minutes, J. Patrick Rowan, Partner at McGuireWoods LLP, will focus on how to determine your true level of FCPA compliance, bring acquired entities into the right compliance fold, and comply with FCPA during international clinical trials.
February 17, 2011
1:00PM EDT / 10:00AM PDT
90 Minutes